- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
c-Met inhibitors ; volume:8 ; number:1 ; day:8 ; month:4 ; year:2013 ; pages:1-2 ; date:12.2013
Infectious agents and cancer ; 8, Heft 1 (8.4.2013), 1-2, 12.2013
- Creator
-
Mughal, Anum
- Contributor
-
Aslam, Hafiz Muhammad
Sheikh, Asfandyar
Khan, Agha Muhammad Hammad
Saleem, Shafaq
SpringerLink (Online service)
- DOI
-
10.1186/1750-9378-8-13
- URN
-
urn:nbn:de:1111-2016072626358
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mughal, Anum
- Aslam, Hafiz Muhammad
- Sheikh, Asfandyar
- Khan, Agha Muhammad Hammad
- Saleem, Shafaq
- SpringerLink (Online service)
Other Objects (12)
Efficacy of c-Met inhibitor for advanced prostate cancer
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
Design, synthesis and biological evaluation of 6‐substituted quinolines derived from cabozantinib as c‐Met inhibitors
c-Met als prognostischer Biomarker im EGFR-mutierten nichtkleinzelligen Lungenkarzinom
c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
Efficacy of c-Met inhibitor for advanced prostate cancer
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
Design, synthesis and biological evaluation of 6‐substituted quinolines derived from cabozantinib as c‐Met inhibitors
c-Met als prognostischer Biomarker im EGFR-mutierten nichtkleinzelligen Lungenkarzinom
c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
Efficacy of c-Met inhibitor for advanced prostate cancer
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
89Zr-Onartuzumab PET imaging of c-MET receptor dynamics
Aptamers Binding to c-Met Inhibiting Tumor Cell Migration
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
Design, synthesis and biological evaluation of 6‐substituted quinolines derived from cabozantinib as c‐Met inhibitors
c-Met als prognostischer Biomarker im EGFR-mutierten nichtkleinzelligen Lungenkarzinom